HUNAN HUATENG PHARMACEUTICAL CO., LTD.
Hunan Huateng Pharmaceutical Co., Ltd is a company committed to research and development, production and sales of high-end PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents. Huateng pharmaceuticals in Chinese, European and American countries have our own R & D and logistics center, the company has an excellent and efficient R & D and production and sales of a professional team. Fast for all global customers to provide professional, personalized and technical support of the one-stop service, can rapid and efficient delivery of products to the customers all around the world.
HUNAN HUATENG PHARMACEUTICAL CO., LTD.
Industry:
Biopharma Biotechnology Chemical Pharmaceutical
Founded:
2013-08-01
Address:
Changshan, Hunan, China
Country:
China
Website Url:
http://www.us.huatengsci.com
Total Employee:
251+
Status:
Active
Contact:
+86 0731-82251112
Email Addresses:
[email protected]
Total Funding:
25.09 M USD
Technology used in webpage:
SPF SSL By Default Google Tag Manager COVID-19 ASP.NET IIS DigiCert SSL IIS 10 ASP.NET 4.0 IIS 8
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Hunan Xingxiang Investment
Hunan Xingxiang Investment investment in Series B - Hunan HuaTeng Pharmaceutical Co., Ltd.
CITIC Securities
CITIC Securities investment in Series B - Hunan HuaTeng Pharmaceutical Co., Ltd.
Boyi Fund
Boyi Fund investment in Series A - Hunan HuaTeng Pharmaceutical Co., Ltd.
Dingteng Juzhi Investment
Dingteng Juzhi Investment investment in Series A - Hunan HuaTeng Pharmaceutical Co., Ltd.
Zhudan Equity Investment Fund
Zhudan Equity Investment Fund investment in Series A - Hunan HuaTeng Pharmaceutical Co., Ltd.
Official Site Inspections
http://www.us.huatengsci.com
- Host name: 47.253.42.205
- IP address: 47.253.42.205
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402